Viewing Study NCT01051934

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:25 AM
Ignite Modification Date: 2026-02-07 @ 6:49 PM
Study NCT ID: NCT01051934
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2010-01-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
None Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recombinant Immunotoxin View
None Monoclonal Antibody View
None Pseudomonas Exotoxin View
None Targeted Therapy View
None Lung Cancer View
None Non-Small Cell Lung Cancer View